---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-21-002236"
form_type: "8-K"
ticker: "ARTL"
cik: "0001621221"
company_name: "ARTELO BIOSCIENCES, INC."
filed_at: "2021-09-17T23:59:59+00:00"
generated_at: "2026-06-29T02:58:17.587852+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Artelo Biosciences receives Nasdaq delisting notice for bid price non-compliance; changes fiscal year end

## Summary
- Received Nasdaq notice on Sept 13, 2021 for failure to meet $1.00 minimum bid price (Listing Rule 5550(a)(2)).
- Has 180 days until March 14, 2022 to regain compliance by closing bid price >= $1.00 for 10 consecutive business days.
- Possible second 180-day cure period if other standards met; otherwise delisting with appeal rights.
- Board resolved on Sept 17, 2021 to change fiscal year end from Aug 31 to Dec 31, effective Jan 1, 2022.
- No immediate effect on listing; company will monitor price and consider options.

## SEC filing metadata
- accession: 0001640334-21-002236
- form_type: 8-K
- ticker: ARTL
- cik: 0001621221
- company_name: ARTELO BIOSCIENCES, INC.
- filed_at: 2021-09-17T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 5.03
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1621221/000164033421002236/0001640334-21-002236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1621221/000164033421002236/artl_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-21-002236
- JSON: https://secwatch.observer/filing/0001640334-21-002236.json
- Plain text: https://secwatch.observer/filing/0001640334-21-002236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.